Issues With the Design of Randomized Trials of Temporary Mechanical Circulatory Support for Cardiogenic Shock

HomeCirculationVol. 147, No. 20Issues With the Design of Randomized Trials of Temporary Mechanical Circulatory Support for Cardiogenic Shock No AccessArticle CommentaryRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessArticle CommentaryRequest AccessFull TextIssues With the Design of Randomized Trials of Temporary Mechanical Circulatory Support for Cardiogenic Shock Jonathan R. Dalzell Jonathan R. DalzellJonathan R. Dalzell Correspondence to: Jonathan R. Dalzell, MBChB, MD, Department of Transplantation and Mechanical Circulatory Support, Scottish National Advanced Heart Failure Service, Golden Jubilee National Hospital, Glasgow, G81 4DY, United Kingdom. Email E-mail Address: [email protected] https://orcid.org/0000-0003-2531-6071 Department of Transplantation and Mechanical Circulatory Support, Scottish National Advanced Heart Failure Service, Golden Jubilee National Hospital, Glasgow, United Kingdom. Search for more papers by this author Originally published15 May 2023https://doi.org/10.1161/CIRCULATIONAHA.122.063616Circulation. 2023;147:1489–1491FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.For Sources of Funding and Disclosures, see page 1491.Circulation is available at www.ahajournals.org/journal/circCorrespondence to: Jonathan R. Dalzell, MBChB, MD, Department of Transplantation and Mechanical Circulatory Support, Scottish National Advanced Heart Failure Service, Golden Jubilee National Hospital, Glasgow, G81 4DY, United Kingdom. Email jonathan.[email protected]scot.nhs.ukReferences1. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, et al; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock.N Engl J Med. 2012; 367:1287–1296. doi: 10.1056/NEJMoa1208410CrossrefMedlineGoogle Scholar2. Schrage B, Ibrahim K, Loehn T, Werner N, Sinning J-M, Pappalardo F, Pieri M, Skurk C, Lauten A, Landmesser U, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock.Circulation. 2019; 139:1249–1258. doi: 10.1161/CIRCULATIONAHA.118.036614LinkGoogle Scholar3. Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, Naar J, Smalcova J, Hubatova M, Hromadka M, et al; ECMO-CS Investigators. Extra-corporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomised clinical trial.Circulation. 2023; 147:454–464. doi: 10.1161/CIRCULATIONAHA.122.062949LinkGoogle Scholar4. Akodad M, Delmas C, Bonello L, Duflos C, Roubille F. Intra-aortic balloon pump: is the technique really outdated?ESC Heart Fail. 2020; 7:1025–1030. doi: 10.1002/ehf2.12721CrossrefMedlineGoogle Scholar5. Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, Berkowitz AP, Masoudi FA, Messenger JC, Parzynski CS, et al. Use of mechanical circulatory support devices among patients with acute myocardial infarction complicated by cardiogenic shock.JAMA Netw Open. 2021; 4:e2037748. doi: 10.1001/jamanetworkopen.2020.37748CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails May 16, 2023Vol 147, Issue 20 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.122.063616PMID: 37186686 Originally publishedMay 15, 2023 Keywordsintra-aortic balloon pumpextracorporeal membrane oxygenationcardiogenic shockheart-assist devicePDF download Advertisement SubjectsCardiopulmonary Resuscitation and Emergency Cardiac CareHeart Failure